Trademark: 90902865
Word
CONVERSALL
Status
Registered
Status Code
700
Status Date
Tuesday, November 22, 2022
Serial Number
90902865
Registration Number
6908553
Registration Date
Tuesday, November 22, 2022
Mark Type
4000
Filing Date
Wednesday, August 25, 2021
Published for Opposition
Tuesday, January 25, 2022

Trademark Owner History
Vivera Pharmaceuticals Inc. - Original Registrant

Classifications
5 Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of mental health disorders; Medical preparations for the treatment of stuttering; Medical preparations for the treatment of diabetes; Nutritional supplements; Pharmaceutical preparations for mental health disorders; Pharmaceutical preparations for stuttering; Pharmaceutical preparations for diabetes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sexual stimulant preparations in the form of sublingual tablets containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual capsules containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual gel strips containing sildenafil citrate

Trademark Events
Mar 7, 2024
Withdrawal Of Attorney Granted
Mar 7, 2024
Teas Withdrawal Of Attorney Received
Nov 22, 2022
Notice Of Registration Confirmation Emailed
Nov 22, 2022
Registered-Principal Register
Oct 18, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 17, 2022
Allowed Principal Register - Sou Accepted
Oct 6, 2022
Statement Of Use Processing Complete
Sep 22, 2022
Use Amendment Filed
Oct 5, 2022
Case Assigned To Intent To Use Paralegal
Sep 22, 2022
Teas Statement Of Use Received
Mar 22, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 25, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 25, 2022
Published For Opposition
Jan 5, 2022
Notification Of Notice Of Publication E-Mailed
Dec 22, 2021
Approved For Pub - Principal Register
Dec 21, 2021
Assigned To Examiner
Oct 12, 2021
New Application Office Supplied Data Entered
Aug 28, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24